Two Sigma Securities’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Two Sigma Securities’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,650	Closed	-$4.1K	–	3525
2023 Q1	$4.1K	Buy	25,650 +5,612	+28%	+$2.49K	﹤0.01%	2540
2022 Q4	$11.1K	Buy	+20,038	New	+$17K	﹤0.01%	2344
2021 Q4	–	Sell	-11,428	Closed	-$39K	–	2175
2021 Q3	$39K	Buy	+11,428	New	+$35.2K	﹤0.01%	1407
2019 Q3	–	Sell	-15,942	Closed	-$29K	–	2555
2019 Q2	$29K	Buy	+15,942	New	+$25.7K	﹤0.01%	1923
2019 Q1	–	Sell	-34,131	Closed	-$40K	–	2576
2018 Q4	$40K	Buy	+34,131	New	+$61.4K	﹤0.01%	1946
2017 Q4	–	Sell	-20,279	Closed	-$27K	–	2081
2017 Q3	$27K	Buy	+20,279	New	+$25.2K	﹤0.01%	804

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Securities's INFI Position: Q2 2023 in Review

Two Sigma Securities sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2023, closing a stake of 25,650 shares — an estimated $4.1K sold.

Two Sigma Securities first reported a position in INFI in Q3 2017 and held it in 6 quarters. The position peaked at $40K in Q4 2018. 45 funds tracked by Wall St. Rank hold INFI as of Q2 2023.

Two Sigma Securities reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Two Sigma Securities sold 25,650 Infinity Pharmaceuticals, Inc. shares in Q2 2023, an estimated $4.1K.
Two Sigma Securities first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2017 and held it in 6 quarters.
Two Sigma Securities's Infinity Pharmaceuticals, Inc. position peaked at $40K in Q4 2018.
45 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.